Home » Products & Technology » T2Dx Instrument

T2Dx Instrument

Breakthrough technology enabling direct detection from whole blood

The FDA-cleared T2Dx^®Instrument is a fully automated, walk away, clinical multiplex benchtop diagnostic system capable of running tests directly from whole blood.

The benefits of the T2Dx Instrument include

Rapid results: Species-specific results in 3 to 5 hours with no up-front sample preparation.
Easy to operate: Fully automated system with minimal hands-on time; a sample tube and a reagent tray snap onto a cartridge, which is then inserted into the instrument.
Performs with 4 mL whole blood: No blood culture is required to receive T2 identification results for targeted pathogens.
Random access: 7 individual, random access drawers can be loaded at any time. No batching is required.
Simple user interface: User-friendly touchscreen display provides step-by-step text and illustrative prompts that guide the operator to load a sample, all in 10 minutes or less.
One instrument, multiple tests: The T2Dx Instrument runs the FDA-cleared T2Bacteria and T2Candida Panels as well as the T2SARS-CoV-2 Panel, which was awarded Emergency Use Authorization (EUA) by the FDA.

The T2Dx Instrument serves nearly 200 hospitals worldwide and is powered by T2 Magnetic Resonance (T2MR^®) technology.

VIDEO

Watch how the T2Dx Instrument works.

T2 BIOSYSTEMS OVERVIEW

T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before. T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most expensive conditions in hospitals today.

The T2Dx Instrument, the T2Bacteria and T2Candida Panels have received marketing authorization from the U.S. Food and Drug Administration. All other T2 Biosystems products are considered investigational and for research use only.

T2 Biosystems®, T2MR®, T2Bacteria®, T2Candida®, and T2Dx® are registered trademarks of T2 Biosystems, Inc. “T2Biosystems” and the T2 Biosystems, Inc. logo design are registered trademarks or trademarks of T2Biosystems, Inc. All software and documentation is subject to T2 Biosystems, Inc. copyrights. All rights reserved. T2Direct Diagnostics™, T2HemoStat™, T2Plex™, T2Cauris™, T2Resistance™ and T2SARS-CoV-2™ are trademarks of T2 Biosystems, Inc.

JOIN IN ON TWITTER

T2 Biosystems

@T2Bio

This new data show that #Candidaauris infections have increased dramatically in the U.S. in recent years. By adding C. auris to our T2Candida Panel, we hope to improve time to detection and treatment for patients affected by this deadly fungus

March 24, 2023

T2 Biosystems

@T2Bio

Today, we affirmed our plans to add the deadly fungus Candida auris to our FDA-cleared T2Candida Panel. #Candidaauris #fungi #fungus #diagnostics #healthcare #patients #hospitals

March 23, 2023

SITEMAP

FOLLOW US ON SOCIAL

Please tell us where you are visiting from: United States | Outside the United States